Elisabetta Munzone, MD
European Institute of Oncology · European Istitute of Oncology · European Institute of Oncology, Milano
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Elisabetta Munzone, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:52 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07049133 · Toxicity Markers to Trastuzumab-Deruxtecan (T-DXd) In Patients With Advanced Breast CancerEuropean Institute of Oncology · recruiting · Metastatic Breast Cancer · principal investigator
- Ph2NCT06690840 · Atezolizumab and Chemotherapy Treatment as T-cell Activators in Metastatic Triple Negative Breast Cancer PatientsEuropean Institute of Oncology · recruiting · Triple Negative Breast Cancer · principal investigator
- Ph2NCT05896566 · A Window-of-Opportunity Trial of Giredestrant +/- Triptorelin vs. Anastrozole + Triptorelin in Premenopausal Patients With ER-positive/HER2-negative Early Breast CancerETOP IBCSG Partners Foundation · completed · Breast Cancer · study chair
- Ph3NCT03820830 · Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast CancerETOP IBCSG Partners Foundation · active not recruiting · Breast Cancer Recurrent · study chair
- N/ANCT03712696 · Efficacy and Safety of DIGNICAP™ SystemEuropean Institute of Oncology · completed · Breast Cancer, Chemotherapy-induced Alopecia · principal investigator
- Ph2NCT03712956 · CAELYX® as Adjuvant Treatment in Early Stage Luminal B Breast Cancer BREAST CANCEREuropean Institute of Oncology · unknown · Breast Cancer · principal investigator
- Ph2NCT02954055 · MEtronomic TrEatment Option in Advanced bReast cAncerETOP IBCSG Partners Foundation · completed · Breast Cancer · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:52 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in breast cancer.